Company Filing History:
Years Active: 2017
Title: Koji Ohmoto: Innovator in Injectable Formulations
Introduction
Koji Ohmoto is a prominent inventor based in Osaka, Japan. He is known for his significant contributions to the field of pharmaceutical formulations. His work focuses on developing innovative solutions for medical treatments, particularly in the area of kidney diseases.
Latest Patents
Ohmoto holds a patent for an "Injectable depot formulation comprising optically active tolvaptan and process of producing the same." This invention provides an injectable formulation that can be administered intramuscularly or subcutaneously. It is designed for the prevention or treatment of polycystic kidney disease. The formulation maintains a therapeutically effective blood concentration of tolvaptan for an extended period. The patent details a process for producing this formulation, which includes a particle containing optically active tolvaptan as the active ingredient and a pharmaceutically acceptable carrier for injection.
Career Highlights
Koji Ohmoto is associated with Otsuka Pharmaceutical Company, Limited, where he has made significant strides in pharmaceutical research and development. His work has contributed to advancements in treatment options for patients suffering from chronic conditions.
Collaborations
Ohmoto has collaborated with notable colleagues, including Daiki Kaneko and Takakuni Matsuda. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Koji Ohmoto's contributions to injectable formulations represent a significant advancement in the treatment of polycystic kidney disease. His innovative approach and dedication to research continue to impact the pharmaceutical industry positively.